Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery

Mostrar otras versiones (1)

BACKGROUND: Schizophrenia is mostly a chronic disorder whose symptoms include psychosis, negative symptoms and cognitive dysfunction. Poor adherence is common and related relapse can impair outcomes. Long-acting injectable antipsychotics (LAIs) may promote treatment adherence and decrease the likeli...

Descripción completa

Detalles Bibliográficos
Autores principales: Arango, Celso, Fagiolini, Andrea, Gorwood, Philip, Kane, John M., Diaz-Mendoza, Sergio, Sahota, Navdeep, Correll, Christoph U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286361/
https://www.ncbi.nlm.nih.gov/pubmed/37344763
http://dx.doi.org/10.1186/s12888-023-04928-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286361/
https://www.ncbi.nlm.nih.gov/pubmed/37344763
http://dx.doi.org/10.1186/s12888-023-04928-0

Ejemplares similares